A new stent for people with coronary artery disease
Part of Heart & circulation clinical trials.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have coronary artery disease and need a procedure to open blocked arteries (PCI)
- You have one or two new blockages in your heart arteries that are at least 70% blocked
- The blocked artery is between 2.5 and 3.5 mm wide, and the blockage is no longer than 36 mm
- You are not pregnant or breastfeeding, and you have no major health issues like severe heart failure, recent heart attack, or allergies to certain medicines or metals
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new type of heart stent in people who also take daily blood thinners. The stent is very thin and releases medicine over time to help keep the artery open, and the coating eventually dissolves. It may be a safer option for people on blood thinners who need a stent.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This study tracks how well a newer heart stent (a small metal tube that keeps arteries open) works in real patients. Researchers want to understand if this specific stent design is safe and effective over time.
This trial tests a longer-than-usual drug-coated stent (Orsiro Mission) for treating long blockages in heart arteries. It aims to see if the stent is safe and effective for people with coronary artery disease.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.